Rehabilitation interventions in randomized controlled trials for low back pain: proof of statistical significance often is not relevant.

Data interpretation Epidemiologic methods Patient outcome assessment Randomized clinical minimal clinically important difference Sample size Statistical Trials

Journal

Health and quality of life outcomes
ISSN: 1477-7525
Titre abrégé: Health Qual Life Outcomes
Pays: England
ID NLM: 101153626

Informations de publication

Date de publication:
22 Jul 2019
Historique:
received: 15 01 2019
accepted: 11 07 2019
entrez: 24 7 2019
pubmed: 25 7 2019
medline: 8 10 2019
Statut: epublish

Résumé

An observed statistically significant difference between two interventions does not necessarily imply that this difference is clinically important for patients and clinicians. We aimed to assess if treatment effects of randomized controlled trials (RCTs) for low back pain (LBP) are statistically significant and clinically relevant, and if RCTs were powered to achieve clinically relevant differences on continuous outcomes. We searched for all RCTs included in Cochrane Systematic Reviews focusing on the efficacy of rehabilitation interventions for LBP and published until April 2017. RCTs having sample size calculation and a planned minimal important difference were considered. In the primary analysis, we calculated the proportion of RCTs classified as "statistically significant and clinically relevant", "statistically significant but not clinically relevant", "not statistically significant but clinically relevant", and "not statistically significant and not clinically relevant". Then, we investigated how many times the mismatch between statistical significance and clinical relevance was due to inadequate power. From 20 eligible SRs including 101 RCTs, we identified 42 RCTs encompassing 81 intervention comparisons. Overall, 60% (25 RCTs) were statistically significant while only 36% (15 RCTs) were both statistically and clinically significant. Most trials (38%) did not discuss the clinical relevance of treatment effects when results did not reached statistical significance. Among trials with non-statistically significant findings, 60% did not reach the planned sample size, therefore being at risk to not detect an effect that is actually there (type II error). Only a minority of positive RCT findings was both statistically significant and clinically relevant. Scarce diligence or frank omissions of important tactic elements of RCTs, such as clinical relevance, and power, decrease the reliability of study findings to current practice.

Sections du résumé

BACKGROUND BACKGROUND
An observed statistically significant difference between two interventions does not necessarily imply that this difference is clinically important for patients and clinicians. We aimed to assess if treatment effects of randomized controlled trials (RCTs) for low back pain (LBP) are statistically significant and clinically relevant, and if RCTs were powered to achieve clinically relevant differences on continuous outcomes.
METHODS METHODS
We searched for all RCTs included in Cochrane Systematic Reviews focusing on the efficacy of rehabilitation interventions for LBP and published until April 2017. RCTs having sample size calculation and a planned minimal important difference were considered. In the primary analysis, we calculated the proportion of RCTs classified as "statistically significant and clinically relevant", "statistically significant but not clinically relevant", "not statistically significant but clinically relevant", and "not statistically significant and not clinically relevant". Then, we investigated how many times the mismatch between statistical significance and clinical relevance was due to inadequate power.
RESULTS RESULTS
From 20 eligible SRs including 101 RCTs, we identified 42 RCTs encompassing 81 intervention comparisons. Overall, 60% (25 RCTs) were statistically significant while only 36% (15 RCTs) were both statistically and clinically significant. Most trials (38%) did not discuss the clinical relevance of treatment effects when results did not reached statistical significance. Among trials with non-statistically significant findings, 60% did not reach the planned sample size, therefore being at risk to not detect an effect that is actually there (type II error).
CONCLUSION CONCLUSIONS
Only a minority of positive RCT findings was both statistically significant and clinically relevant. Scarce diligence or frank omissions of important tactic elements of RCTs, such as clinical relevance, and power, decrease the reliability of study findings to current practice.

Identifiants

pubmed: 31331343
doi: 10.1186/s12955-019-1196-8
pii: 10.1186/s12955-019-1196-8
pmc: PMC6647152
doi:

Types de publication

Journal Article Systematic Review

Langues

eng

Sous-ensembles de citation

IM

Pagination

127

Subventions

Organisme : Ministero della Salute
ID : L3018
Organisme : Ministero della Salute (IT)
ID : GR-2011-02348048

Références

Spine (Phila Pa 1976). 2000 Dec 15;25(24):3186-91
pubmed: 11124735
CMAJ. 2001 Oct 30;165(9):1197-202
pubmed: 11706908
Lancet. 2006 Feb 11;367(9509):449-50
pubmed: 16473106
Spine (Phila Pa 1976). 2006 Mar 1;31(5):578-82
pubmed: 16508555
Spine (Phila Pa 1976). 2007 Jul 15;32(16):1785-90
pubmed: 17632400
Spine (Phila Pa 1976). 2008 Jan 1;33(1):90-4
pubmed: 18165753
N Engl J Med. 2008 Jan 17;358(3):252-60
pubmed: 18199864
Ann Intern Med. 2008 Feb 19;148(4):295-309
pubmed: 18283207
PLoS Med. 2008 Nov 25;5(11):e217; discussion e217
pubmed: 19067477
J Am Geriatr Soc. 2009 Mar;57(3):536-46
pubmed: 19187414
Am J Phys Med Rehabil. 2010 Feb;89(2):160-72
pubmed: 20090428
Arch Phys Med Rehabil. 2011 Feb;92(2):306-15
pubmed: 21272730
J Clin Epidemiol. 2011 Dec;64(12):1283-93
pubmed: 21839614
J Clin Epidemiol. 2012 Mar;65(3):301-8
pubmed: 22169081
JAMA. 2013 Feb 27;309(8):814-22
pubmed: 23443445
Respir Care. 2013 Nov;58(11):1899-906
pubmed: 23592789
Trials. 2014 Sep 17;15:362
pubmed: 25230673
Arch Phys Med Rehabil. 2016 Jul;97(7):1195-201
pubmed: 26971671
Res Involv Engagem. 2015 Jun 25;1:2
pubmed: 29062491
Health Qual Life Outcomes. 2018 May 15;16(1):91
pubmed: 29764423
N Engl J Med. 1978 Sep 28;299(13):690-4
pubmed: 355881
Biometrics. 1987 Sep;43(3):487-98
pubmed: 3663814
BMJ. 1995 Jul 1;311(6996):61
pubmed: 7677870
JAMA. 1994 Jul 13;272(2):122-4
pubmed: 8015121
BMJ. 1996 Jan 13;312(7023):71-2
pubmed: 8555924
J Clin Epidemiol. 1996 Nov;49(11):1221-2
pubmed: 8892487

Auteurs

Silvia Gianola (S)

IRCCS Istituto Ortopedico Galeazzi, Unit of Clinical Epidemiology, Milan, Italy. silvia.gianola@grupposandonato.it.

Greta Castellini (G)

IRCCS Istituto Ortopedico Galeazzi, Unit of Clinical Epidemiology, Milan, Italy.
Department of Biomedical Sciences for Health, University of Milan, Milan, Italy.

Davide Corbetta (D)

IRCCS San Raffaele Hospital, Rehabilitation and Functional Recovery Department, Milan, Italy.
Vita-Salute San Raffaele University, Physiotherapy Degree Course, Milan, Italy.

Lorenzo Moja (L)

IRCCS Istituto Ortopedico Galeazzi, Unit of Clinical Epidemiology, Milan, Italy.
Department of Biomedical Sciences for Health, University of Milan, Milan, Italy.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH